新质生产力赋能傣医药产业化发展:逻辑、困境与策略OA

Objective Against the backdrop of the rapid development of new-quality productivity,the traditional ethnic medicine industry is in urgent need of transformation and upgrading.This research aims to analyze the bottlenecks encountered in the industrialization of Dai medicine and put forward systematic solutions from the perspective of new-quality productivity,offering a reference for the upgrading of characteristic industries in border regions.Methods By employing the multi-dimensional comparison method,this study systematically contrasts the current development situations of Dai medicine with those of other ethnic medicines such as Tibetan,Mongolian,and Uyghur medicines.Based on the"technology-industry-institution-culture"framework,it dissects the key restrictive factors in the industrialization of Dai medicine.Results The research reveals that the industrialization of Dai medicine confronts four major bottlenecks:feeble technological R&D,the lack of sustainable resource utilization,the absence of a standard system,and the disjunction in talent cultivation.In response to these problems,this study presents the following solutions:① Digital inheritance and the application of intelligent technologies;② The establishment of a modern standardization system;③ The development of an integrated model of"culture-tourism and healthcare";④ The coordinated promotion of policies,talents,and industrial chains.Empirical data indicate that this solution has yielded remarkable results:the development of products with both medicinal and edible properties has led to a 14.7%increase in employment,and the"culture-tourism and healthcare"model has contributed to a 22%growth in tourism revenue.Conclusion This research validates the suitability of new-quality productivity in the industrialization of Dai medicine.The constructed two-way circulation mechanism of"technology enabling-industry feedback"provides a replicable paradigm for the upgrading of characteristic industries in border regions.In the future,the application potential of this model in other ethnic medicine industries can be further explored.